These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 26279690)
1. Radioiodine Scan Index: A Simplified, Quantitative Treatment Response Parameter for Metastatic Thyroid Carcinoma. Oh JR; Ahn BC; Jeong SY; Lee SW; Lee J Nucl Med Mol Imaging; 2015 Sep; 49(3):174-81. PubMed ID: 26279690 [TBL] [Abstract][Full Text] [Related]
2. Radioiodine whole-body scans, thyroglobulin levels, 99mTc-MIBI scans and computed tomography: results in patients with lung metastases from differentiated thyroid cancer. Küçük ON; Gültekin SS; Aras G; Ibiş E Nucl Med Commun; 2006 Mar; 27(3):261-6. PubMed ID: 16479246 [TBL] [Abstract][Full Text] [Related]
3. Management of differentiated thyroid cancer with rising thyroglobulin and negative diagnostic radioiodine whole body scan. Chao M Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):438-47. PubMed ID: 20561773 [TBL] [Abstract][Full Text] [Related]
4. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma. Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882 [TBL] [Abstract][Full Text] [Related]
5. The use of non-specific tracers in the follow up of differentiated thyroid cancer: results with Tc-99m tetrofosmin whole body scintigraphy. Lind P; Gallowitsch HJ Acta Med Austriaca; 1996; 23(1-2):69-75. PubMed ID: 8767519 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer. Lima N; Cavaliere H; Tomimori E; Knobel M; Medeiros-Neto G J Endocrinol Invest; 2002 Feb; 25(2):110-5. PubMed ID: 11929080 [TBL] [Abstract][Full Text] [Related]
7. Low correlation between serum thyroglobulin and Thai JN; De Marchena IR; Nehru VM; Landau E; Demissie S; Josemon R; Peti S; Brenner AI Clin Imaging; 2022 Jul; 87():1-4. PubMed ID: 35439719 [TBL] [Abstract][Full Text] [Related]
8. The role of 18F-Fluorodeoxyglucose Positron Emission Tomography in patients with suspected recurrence or metastatic differentiated thyroid carcinoma with elevated serum thyroglobulin and negative I-131 whole body scan. Trybek T; Kowalska A; Lesiak J; Młynarczyk J Nucl Med Rev Cent East Eur; 2014; 17(2):87-93. PubMed ID: 25088108 [TBL] [Abstract][Full Text] [Related]
9. Importance of postoperative stimulated thyroglobulin level at the time of 131I ablation therapy for differentiated thyroid cancer. Hasbek Z; Turgut B; Kilicli F; Altuntas EE; Yucel B Asian Pac J Cancer Prev; 2014; 15(6):2523-7. PubMed ID: 24761858 [TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of Basal Serum Thyroglobulin Levels, but Not Basal Antithyroglobulin Antibody (TgAb) Levels, in Patients with Differentiated Thyroid Cancer. Neshandar Asli I; Siahkali AS; Shafie B; Javadi H; Assadi M Mol Imaging Radionucl Ther; 2014 Jun; 23(2):54-9. PubMed ID: 24963446 [TBL] [Abstract][Full Text] [Related]
11. Examining recombinant human TSH primed ¹³¹I therapy protocol in patients with metastatic differentiated thyroid carcinoma: comparison with the traditional thyroid hormone withdrawal protocol. Rani D; Kaisar S; Awasare S; Kamaldeep ; Abhyankar A; Basu S Eur J Nucl Med Mol Imaging; 2014 Sep; 41(9):1767-80. PubMed ID: 24687139 [TBL] [Abstract][Full Text] [Related]
13. Role of Preablative Stimulated Thyroglobulin in Prediction of Nodal and Distant Metastasis on Iodine Whole-Body Scan. Prabhu M; Samson S; Reddy A; Venkataramanarao SH; Chandrasekhar NH; Pillai V; Shetty V; Koriokose MA; Vaidhya B; Kannan S Indian J Nucl Med; 2018; 33(2):93-98. PubMed ID: 29643667 [TBL] [Abstract][Full Text] [Related]
14. A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer. Haugen BR; Pacini F; Reiners C; Schlumberger M; Ladenson PW; Sherman SI; Cooper DS; Graham KE; Braverman LE; Skarulis MC; Davies TF; DeGroot LJ; Mazzaferri EL; Daniels GH; Ross DS; Luster M; Samuels MH; Becker DV; Maxon HR; Cavalieri RR; Spencer CA; McEllin K; Weintraub BD; Ridgway EC J Clin Endocrinol Metab; 1999 Nov; 84(11):3877-85. PubMed ID: 10566623 [TBL] [Abstract][Full Text] [Related]
15. Follow-up of differentiated thyroid carcinoma. Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026 [TBL] [Abstract][Full Text] [Related]
16. Unusual Sites of Metastatic and Benign I 131 Uptake in Patients with Differentiated Thyroid Carcinoma. Palaniswamy SS; Subramanyam P Indian J Endocrinol Metab; 2018; 22(6):740-750. PubMed ID: 30766811 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in differentiated thyroid cancer patients with elevated thyroglobulin and negative (131)I whole body scan: evaluation by thyroglobulin level. Na SJ; Yoo IeR; O JH; Lin C; Lin Q; Kim SH; Chung SK Ann Nucl Med; 2012 Jan; 26(1):26-34. PubMed ID: 21971605 [TBL] [Abstract][Full Text] [Related]
18. Difference of clinical and radiological characteristics according to radioiodine avidity in pulmonary metastases of differentiated thyroid cancer. Kim DH; Jung JH; Son SH; Kim CY; Hong CM; Jeong SY; Lee SW; Lee J; Ahn BC Nucl Med Mol Imaging; 2014 Mar; 48(1):55-62. PubMed ID: 24900139 [TBL] [Abstract][Full Text] [Related]
19. [Investigating patients with differentiated thyroid carcinoma and elevated serum thyroglobulin but negative whole-body scan]. Rosário PW; Maia FC; Barroso AL; Purisch S Arq Bras Endocrinol Metabol; 2005 Apr; 49(2):246-52. PubMed ID: 16184253 [TBL] [Abstract][Full Text] [Related]
20. Use of Wu D; Ylli D; Gomes Lima CJ; Lee W; Burman KD; Wartofsky L; Van Nostrand D Endocrine; 2018 Oct; 62(1):57-63. PubMed ID: 29797211 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]